» Articles » PMID: 32581830

Hypertrophic and Dilated Cardiomyopathy-Associated Troponin T Mutations R130C and ΔK210 Oppositely Affect Length-Dependent Calcium Sensitivity of Force Generation

Overview
Journal Front Physiol
Date 2020 Jun 26
PMID 32581830
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Length-dependent activation of calcium-dependent myocardial force generation provides the basis for the Frank-Starling mechanism. To directly compare the effects of mutations associated with hypertrophic cardiomyopathy and dilated cardiomyopathy, the native troponin complex in skinned trabecular fibers of guinea pigs was exchanged with recombinant heterotrimeric, human, cardiac troponin complexes containing different human cardiac troponin T subunits (hcTnT): hypertrophic cardiomyopathy-associated hcTnT, dilated cardiomyopathy-associated hcTnT or the wild type hcTnT (hcTnT) serving as control. Force-calcium relations of exchanged fibers were explored at short fiber length defined as 110% of slack length ( ) and long fiber length defined as 125% of (1.25 ). At short fiber length (1.1 ), calcium sensitivity of force generation expressed by -log [Ca] required for half-maximum force generation (pCa) was highest for the hypertrophic cardiomyopathy-associated mutation R130C (5.657 ± 0.019), intermediate for the wild type control (5.580 ± 0.028) and lowest for the dilated cardiomyopathy-associated mutation ΔK210 (5.325 ± 0.038). Lengthening fibers from 1.1 to 1.25 increased calcium sensitivity in fibers containing hcTnT (delta-pCa = +0.030 ± 0.010), did not alter calcium sensitivity in the wild type control (delta-pCa = -0.001 ± 0.010), and decreased calcium sensitivity in fibers containing hcTnT (delta-pCa = -0.034 ± 0.013). Length-dependent activation indicated by the delta-pCa was highly significantly ( < 0.001) different between the two mutations. We hypothesize that primary effects of mutations on length-dependent activation contribute to the development of the diverging phenotypes in hypertrophic and dilated cardiomyopathy.

Citing Articles

Emerging Concepts of Mechanisms Controlling Cardiac Tension: Focus on Familial Dilated Cardiomyopathy (DCM) and Sarcomere-Directed Therapies.

Solaro R, Goldspink P, Wolska B Biomedicines. 2024; 12(5).

PMID: 38790961 PMC: 11117855. DOI: 10.3390/biomedicines12050999.


Quantitative mapping of force-pCa curves to whole-heart contraction and relaxation.

Longobardi S, Sher A, Niederer S J Physiol. 2022; 600(15):3497-3516.

PMID: 35737959 PMC: 9540007. DOI: 10.1113/JP283352.


Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different Mutations.

Pioner J, Vitale G, Gentile F, Scellini B, Piroddi N, Cerbai E Front Physiol. 2022; 13:864547.

PMID: 35514357 PMC: 9062294. DOI: 10.3389/fphys.2022.864547.

References
1.
Wang S, Zou Y, Fu C, Song L, Wang H, Wang J . [Family hypertrophic cardiomyopathy caused by a 14035c > t mutation in cardiac troponin T gene]. Zhonghua Yi Xue Za Zhi. 2007; 87(6):371-4. View

2.
de Tombe P, Mateja R, Tachampa K, Ait Mou Y, Farman G, Irving T . Myofilament length dependent activation. J Mol Cell Cardiol. 2010; 48(5):851-8. PMC: 2854194. DOI: 10.1016/j.yjmcc.2009.12.017. View

3.
Konhilas J, Irving T, Wolska B, Jweied E, Martin A, Solaro R . Troponin I in the murine myocardium: influence on length-dependent activation and interfilament spacing. J Physiol. 2003; 547(Pt 3):951-61. PMC: 2342721. DOI: 10.1113/jphysiol.2002.038117. View

4.
Hamdani N, Kooij V, Van Dijk S, Merkus D, Paulus W, Dos Remedios C . Sarcomeric dysfunction in heart failure. Cardiovasc Res. 2007; 77(4):649-58. DOI: 10.1093/cvr/cvm079. View

5.
Dvornikov A, Smolin N, Zhang M, Martin J, Robia S, de Tombe P . Restrictive Cardiomyopathy Troponin I R145W Mutation Does Not Perturb Myofilament Length-dependent Activation in Human Cardiac Sarcomeres. J Biol Chem. 2016; 291(41):21817-21828. PMC: 5076848. DOI: 10.1074/jbc.M116.746172. View